Provectus Biopharmaceuticals, Inc.

PVCT ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Oct 23, 2026 4
4 Oct 13, 2026 4
4 Oct 5, 2026 4
4 Sep 18, 2026 4
4 Sep 11, 2026 4
4 Sep 8, 2026 4
4 Aug 26, 2026 4
10-Q Aug 13, 2026 10-Q
SCHEDULE 13D/A Jul 22, 2026
4 Jul 2, 2026 4
8-K Jul 1, 2026 8-K
4 Jun 30, 2026 4
4 Jun 30, 2026 4
4 Jun 30, 2026 4
8-K Jun 22, 2026 8-K
8-K Jun 18, 2026 8-K
4 Jun 5, 2026 4
4 May 29, 2026 4
4 May 26, 2026 4
4 May 15, 2026 4
10-Q May 14, 2026 10-Q
4 May 7, 2026 4
ARS Apr 30, 2026 ARS
DEFA14A Apr 30, 2026 DEFA14A
DEF 14A Apr 30, 2026 DEF 14A
← Newer Page 1 of 43 · 1071 filings Older →